XOMA
Price:
$41.89
Market Cap:
$525.34M
XOMA Royalty Corp. functions as a specialist in aggregating biotechnology royalties, with its operations extending across Europe, the United States, and the Asia Pacific region. The company is dedicated to fostering advancements in human health by collaborating with biotechnology firms. Its core business model involves acquiring the anticipated future economic benefits, such as royalties and milestone payments, associated with pre-market therapeutic candidates that have already been licensed to pharmaceutical or biotechnology firms. The firm focuses its investments on early to mid-stage clinical assets, typically those in Phase 1 and 2 trials, selected for their robust commercial potential a...[Read more]
Industry
Biotechnology
IPO Date
1986-06-06
Stock Exchange
NASDAQ
Ticker
XOMA
According to XOMA Royalty Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 26.68. This represents a change of 12.45% compared to the average of 23.73 of the last 4 quarters.
The mean historical PE Ratio of XOMA Royalty Corp. over the last ten years is 7.96. The current 26.68 PE Ratio has changed 33.41% with respect to the historical average. Over the past ten years (40 quarters), XOMA's PE Ratio was at its highest in in the March 2025 quarter at 83.04. The PE Ratio was at its lowest in in the December 2017 quarter at -55.63.
Average
7.96
Median
-2.53
Minimum
-31.02
Maximum
53.82
Discovering the peaks and valleys of XOMA Royalty Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 289.93%
Maximum Annual PE Ratio = 53.82
Minimum Annual Increase = -10099.49%
Minimum Annual PE Ratio = -31.02
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 17.38 | -209.12% |
| 2024 | -15.93 | 247.82% |
| 2023 | -4.58 | -50.72% |
| 2022 | -9.29 | -130.75% |
| 2021 | 30.22 | -43.85% |
| 2020 | 53.82 | -273.48% |
| 2019 | -31.02 | 289.93% |
| 2018 | -7.96 | -116.76% |
| 2017 | 47.47 | -10099.49% |
| 2016 | -0.47 | -93.75% |
The current PE Ratio of XOMA Royalty Corp. (XOMA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.04
5-year avg
3.56
10-year avg
7.96
XOMA Royalty Corp.’s PE Ratio is greater than Galectin Therapeutics Inc. (-6.94), greater than I-Mab (-17.26), greater than Benitec Biopharma Inc. (-10.95), greater than Rocket Pharmaceuticals, Inc. (-1.79), greater than Solid Biosciences Inc. (-4.27), greater than Quantum-Si incorporated (-1.94), greater than Design Therapeutics, Inc. (-10.37), greater than Aura Biosciences, Inc. (-3.58), greater than Autolus Therapeutics plc (-1.39), greater than DiaMedica Therapeutics Inc. (-8.24),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.94 | $186.05M | |
| -17.26 | $542.01M | |
| -10.95 | $318.90M | |
| -1.79 | $365.80M | |
| -4.27 | $648.99M | |
| -1.94 | $197.62M | |
| -10.37 | $776.96M | |
| -3.58 | $407.03M | |
| -1.39 | $401.88M | |
| -8.24 | $315.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Royalty Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XOMA Royalty Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is XOMA Royalty Corp.'s PE Ratio?
How is the PE Ratio calculated for XOMA Royalty Corp. (XOMA)?
What is the highest PE Ratio for XOMA Royalty Corp. (XOMA)?
What is the 3-year average PE Ratio for XOMA Royalty Corp. (XOMA)?
What is the 5-year average PE Ratio for XOMA Royalty Corp. (XOMA)?
How does the current PE Ratio for XOMA Royalty Corp. (XOMA) compare to its historical average?